Last edition
News about
Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
AstraZeneca to acquire Amolyt Pharma at a purchase price of USD 800 million upfront and a potential milestone payment of USD 250 million. Alexion, AstraZeneca Rare Disease is looking forward to welcoming talent from Amolyt Pharma.
P-BCMA-ALLO1 is a BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen receptor (CAR)-T therapy candidate, currently being investigated in collaboration with Roche for the treatment of relapsed/refractory multiple myeloma (RRMM).
IATA and Pharma.Aero Collaborate to Enhance Pharmaceutical Handling Excellence
The collaborative effort involved meticulous examination of the CEIV Pharma program, engaging certified entities, pharmaceutical manufacturers, and professionals within the air logistics sector.
Silicon Valley Innovations Appoints Thomas M. Krummel to its Board of Directors
Krummel recently received the 2023 Jacobson Innovation Award from the American College of Surgeons, the highest honor nationwide in Surgery, for his pioneering 'life-saving advances in newborn life support' and a 40 year career as an innovator in Surgery.
The acquisition provides Novartis with full rights to IFM Due's portfolio of STING antagonists, which have the potential to treat an array of serious inflammation-driven diseases characterized by excessive interferon and other pro-inflammatory cytokine signaling.
Casio Introduces DZ-C100 COLPOCAMERA and CST-100M Camera Stand to US, Australia and New Zealand
Alongside the devices, the image management software D'z IMAGE Viewer C is also available in these regions, marking a significant expansion of Casio's medical device offerings.
AstraZeneca India and Mankind Pharma Collaborate to Expand Access to Asthma Treatment Across India
India currently accounts for 13 percent of the global asthma burden and a staggering 43 percent of asthma-related deaths worldwide.
ScreenPoint Medical Deploys Transpara Breast AI at Johns Hopkins to Improve Cancer Detection
The Johns Hopkins Kimmel Cancer Center was one of the first to be recognized by the National Cancer Institute as a 'Center of Excellence.'
The collaboration aims to significantly accelerate the development and commercialization of Ratio's pipeline of next-generation radiotherapies, representing a critical component in advancing Ratio's fibroblast activation protein-alpha (FAP)-targeted radiotherapeutic candidate.
Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards
The revised scheme, a significant step in the government's efforts, follows a comprehensive review by the Scheme Steering Committee.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy